Prolongation of biologic dosing intervals in patient with stable psoriasis; a feasibility study

Teun van Gelder

[P26-5-2] Prolongation of biologic dosing intervals in patient with stable psoriasis; a feasibility study

Teun van Gelder¹, Ji Sun van Bezooijen², Martijn van Doorn³, Marco Schreurs⁴, Birgit Koch⁵, Henk te Velthuis⁶, Errol Prens⁷ (1.Erasmus MC, 2.Erasmus MC, 3.Erasmus MC, 4.Erasmus MC, 5.Erasmus MC, 6.Sanquin, 7.Erasmus MC)

キーワード：biologics, adalimumab, etanercept, ustekinumab, dosing interval prolongation

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

講演情報

[P26-5] P26-5: Immunosuppressive drugs (4): Individualized dosage adjustment

[P26-5-2] Prolongation of biologic dosing intervals in patient with stable psoriasis; a feasibility study

パスワード